Market Research Logo

Pharmaceuticals in Russia

Pharmaceuticals in Russia

Summary

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Russian pharmaceuticals market had total revenues of $23.4bn in 2017, representing a compound annual growth rate (CAGR) of 13.7% between 2013 and 2017.
  • A key driver of growth in market is that the country has a high smoking population and high alcohol consumption, which has led to cardiovascular diseases and cancer being prominent ailments.
  • In Russia, the pharmaceutical market is made up of two business segments: the government procurement and the commercial market. The market is largely controlled by the commercial segment, rather than government purchasing.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the Russia pharmaceuticals market by value in 2017?
  • What will be the size of the Russia pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the Russia pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Russia's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Les Laboratoires Servier
Novartis AG
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Russia pharmaceuticals market value: $ billion, 2013-17
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: Russia pharmaceuticals market share: % share, by value, 2017
Table 4: Russia pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Bayer AG: key facts
Table 6: Bayer AG: key financials ($)
Table 7: Bayer AG: key financials (€)
Table 8: Bayer AG: key financial ratios
Table 9: Les Laboratoires Servier: key facts
Table 10: Novartis AG: key facts
Table 11: Novartis AG: key financials ($)
Table 12: Novartis AG: key financial ratios
Table 13: Sanofi SA: key facts
Table 14: Sanofi SA: key financials ($)
Table 15: Sanofi SA: key financials (€)
Table 16: Sanofi SA: key financial ratios
Table 17: Russia size of population (million), 2013-17
Table 18: Russia gdp (constant 2005 prices, $ billion), 2013-17
Table 19: Russia gdp (current prices, $ billion), 2013-17
Table 20: Russia inflation, 2013-17
Table 21: Russia consumer price index (absolute), 2013-17
Table 22: Russia exchange rate, 2013-17
List of Figures
Figure 1: Russia pharmaceuticals market value: $ billion, 2013-17
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: Russia pharmaceuticals market share: % share, by value, 2017
Figure 4: Russia pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2017
Figure 11: Bayer AG: revenues & profitability
Figure 12: Bayer AG: assets & liabilities
Figure 13: Novartis AG: revenues & profitability
Figure 14: Novartis AG: assets & liabilities
Figure 15: Sanofi SA: revenues & profitability
Figure 16: Sanofi SA: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report